Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders.
Konen FF, Möhn N, Witte T, Schefzyk M, Wiestler M, Lovric S, Hufendiek K, Jendretzky KF, Gingele S, Schwenkenbecher P, Sühs KW, Friese MA, Klotz L, Pul R, Pawlitzki M, Hagin D, Kleinschnitz C, Meuth SG, Skripuletz T. Konen FF, et al. Autoimmun Rev. 2025 Jan 20;24(4):103754. doi: 10.1016/j.autrev.2025.103754. Online ahead of print. Autoimmun Rev. 2025. PMID: 39842533 Review.
C5 complement inhibition versus FcRn modulation in generalised myasthenia gravis.
Huntemann N, Gerischer L, Herdick M, Nelke C, Stascheit F, Hoffmann S, Öztürk M, Schroeter CB, Lehnerer S, Stein M, Schubert C, Schneider-Gold C, Pfeuffer S, Krämer HH, Konen FF, Skripuletz T, Pawlitzki M, Glaubitz S, Zschüntzsch J, Scherwietes V, Totzeck A, Hagenacker T, Meuth SG, Meisel A, Ruck T. Huntemann N, et al. Among authors: konen ff. J Neurol Neurosurg Psychiatry. 2025 Jan 11:jnnp-2024-334404. doi: 10.1136/jnnp-2024-334404. Online ahead of print. J Neurol Neurosurg Psychiatry. 2025. PMID: 39798960 Free article.
Different Treatment Outcomes of Multiple Sclerosis Patients Receiving Ocrelizumab or Ofatumumab.
Meuth SG, Wolff S, Mück A, Willison A, Kleinschnitz K, Räuber S, Pawlitzki M, Konen FF, Skripuletz T, Grothe M, Ruck T, Huttner HB, Kleinschnitz C, Bopp T, Pul R, Cree BAC, Hartung HP, Möllenhoff K, Pfeuffer S. Meuth SG, et al. Among authors: konen ff. Ann Neurol. 2024 Nov 25. doi: 10.1002/ana.27143. Online ahead of print. Ann Neurol. 2024. PMID: 39582359
Prevalence of comorbid autoimmune diseases and antibodies in newly diagnosed multiple sclerosis patients.
Jendretzky KF, Lezius LM, Thiele T, Konen FF, Huss A, Heitmann L, Güzeloglu YE, Schwenkenbecher P, Sühs KW, Skuljec J, Wattjes MP, Witte T, Kleinschnitz C, Pul R, Tumani H, Gingele S, Skripuletz T. Jendretzky KF, et al. Among authors: konen ff. Neurol Res Pract. 2024 Nov 12;6(1):55. doi: 10.1186/s42466-024-00351-2. Neurol Res Pract. 2024. PMID: 39533435 Free PMC article.
Optical coherence tomography angiography to assess for retinal vascular changes in Neuro-Sjögren.
Haar M, Konen FF, Gehlhaar MA, Oluwatoba-Popoola I, Donicova E, Wachsmann M, Lubbad A, Hufendiek K, Pielen A, Hohberger B, Mardin C, Gingele S, Prenzler NK, Ernst D, Witte T, Framme C, Skripuletz T, Seeliger T, Bajor A. Haar M, et al. Among authors: konen ff. Ther Adv Ophthalmol. 2024 Oct 31;16:25158414241294024. doi: 10.1177/25158414241294024. eCollection 2024 Jan-Dec. Ther Adv Ophthalmol. 2024. PMID: 39493254 Free PMC article.
Rapid depletion of CD20+ B and T cells following ofatumumab therapy onset.
Konen FF, Gingele S, Hümmert MW, Möhn N, Streichert AL, Kretschmer JR, Grote-Levi L, Nay S, Seeliger T, Ratuszny D, Jendretzky KF, Tkachenko D, Jacobs R, Skripuletz T, Schwenkenbecher P. Konen FF, et al. Mult Scler Relat Disord. 2024 Nov;91:105886. doi: 10.1016/j.msard.2024.105886. Epub 2024 Sep 14. Mult Scler Relat Disord. 2024. PMID: 39299183 Free article.
Identification of disease phenotypes in acetylcholine receptor-antibody myasthenia gravis using proteomics-based consensus clustering.
Nelke C, Schroeter CB, Barman S, Stascheit F, Masanneck L, Theissen L, Huntemann N, Walli S, Cengiz D, Dobelmann V, Vogelsang A, Pawlitzki M, Räuber S, Konen FF, Skripuletz T, Hartung HP, König S, Roos A, Meisel A, Meuth SG, Ruck T. Nelke C, et al. Among authors: konen ff. EBioMedicine. 2024 Jul;105:105231. doi: 10.1016/j.ebiom.2024.105231. Epub 2024 Jul 2. EBioMedicine. 2024. PMID: 38959848 Free PMC article.
Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis.
Schroeter CB, Nelke C, Stascheit F, Huntemann N, Preusse C, Dobelmann V, Theissen L, Pawlitzki M, Räuber S, Willison A, Vogelsang A, Marina AD, Hartung HP, Melzer N, Konen FF, Skripuletz T, Hentschel A, König S, Schweizer M, Stühler K, Poschmann G, Roos A, Stenzel W, Meisel A, Meuth SG, Ruck T. Schroeter CB, et al. Among authors: konen ff. Acta Neuropathol. 2024 Jun 18;147(1):102. doi: 10.1007/s00401-024-02754-6. Acta Neuropathol. 2024. PMID: 38888758 Free PMC article.
39 results